Brief: Xbrane Biopharma Enters Into SEK 60 Mln Financing Solution With Fenja
17/10/2025 07:34
Oct 17 (Reuters) - Xbrane Biopharma AB XBRANE.ST: SAID ON THURSDAY ENTERS INTO CONDITIONAL FINANCING SOLUTION WITH FENJA CAPITAL II A/S SOLUTION PROVIDING LOAN OF SEK 60 MLN TO BE TRIGGERED IN THE EVENT OF DELAY IN ANTICIPATED US FDA APPROVAL OF LUCAMZI REMAINS OPTIMISTIC REGARDING APPROVAL ON UPCOMING BSUFA DATE ON OCT 21, BUT DECIDED TO ENTER INTO THIS FINANCING SOLUTION TO PROACTIVELY SECURE CO'S WORKING CAPITAL NEEDS IN CASE OF DELAY Source text for Workspace: nMFN3yNFBV Further company coverage: XBRANE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))